Efficacy of intracoronary nicardipine in the treatment of no‐reflow during percutaneous coronary intervention
- 25 October 2006
- journal article
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 68 (5), 671-676
- https://doi.org/10.1002/ccd.20885
Abstract
Objectives: The goal of this study was to evaluate the safety and efficacy of nicardipine in reversing no‐reflow during percutaneous coronary intervention (PCI). Background: No‐reflow is a common complication of PCI in patients with acute coronary syndromes or venous bypass graft disease. Although nicardipine has an attractive pharmacological profile and has been used clinically to treat no‐reflow, there is a paucity of published data regarding its effectiveness in this setting. Methods: We conducted a retrospective analysis of 72 consecutive patients who received intracoronary nicardipine to reverse no‐reflow during coronary intervention. Qualitative TIMI flow grade and quantitative TIMI frame count methods were used to assess the efficacy of nicardipine. Results: A mean of 460 ± 360 mcg of intracoronary nicardipine was used. No‐reflow was successfully reversed with complete restoration of TIMI 3 flow in 71 of 72 patients (98.6%). TIMI flow grade improved from 1.65 ± 0.53 prior to nicardipine to 2.97 ± 0.24 after treatment (P < 0.001). TIMI frame count decreased from 57 ± 40 at the time of no‐reflow to 15 ± 12 after nicardipine administration (P < 0.001). Nicardipine therapy was well tolerated without adverse hemodynamic or chronotropic effects.Conclusions: In this largest series to date, intracoronary nicardipine was demonstrated to be a safe and highly effective pharmacological agent to reverse no‐reflow during PCI.Keywords
This publication has 31 references indexed in Scilit:
- Society of cardiac angiography and interventions: Suggested management of the no-reflow phenomenon in the cardiac catheterization laboratoryCatheterization and Cardiovascular Interventions, 2003
- No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary interventionAmerican Heart Journal, 2003
- Further insights into the no-reflow phenomenon after primary angioplasty in acute myocardial infarction: The role of microthromboemboliJournal of the American Society of Echocardiography, 2003
- No-Reflow PhenomenonCirculation, 2002
- The coronary no-reflow phenomenon: a review of mechanisms and therapiesEuropean Heart Journal, 2001
- Coronary vasomotion during dynamic exercise: Influence of intravenous and intracoronary nicardipineJournal of the American College of Cardiology, 1995
- Features and outcome of no-reflow after percutaneous coronary interventionThe American Journal of Cardiology, 1995
- Incidence and treatment of 'no-reflow' after percutaneous coronary intervention.Circulation, 1994
- Effects of intravenous and intracoronary nicardipineThe American Journal of Cardiology, 1989
- No-reflow phenomenon during percutaneous transluminal coronary angioplastyAmerican Heart Journal, 1988